Cargando…
The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2425468/ https://www.ncbi.nlm.nih.gov/pubmed/18442994 http://dx.doi.org/10.1093/nar/gkn177 |
_version_ | 1782156261642469376 |
---|---|
author | Kuciak, Monika Gabus, Caroline Ivanyi-Nagy, Roland Semrad, Katharina Storchak, Roman Chaloin, Olivier Muller, Sylviane Mély, Yves Darlix, Jean-Luc |
author_facet | Kuciak, Monika Gabus, Caroline Ivanyi-Nagy, Roland Semrad, Katharina Storchak, Roman Chaloin, Olivier Muller, Sylviane Mély, Yves Darlix, Jean-Luc |
author_sort | Kuciak, Monika |
collection | PubMed |
description | The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transcriptional activator named Tat. The Tat protein is absolutely required for virus replication since it controls proviral DNA transcription to generate the full-length viral mRNA. Tat can also regulate mRNA capping and splicing and was recently found to interfere with the cellular mi- and siRNA machinery. Because of its extensive interplay with nucleic acids, and its basic and disordered nature we speculated that Tat had nucleic acid-chaperoning properties. This prompted us to examine in vitro the nucleic acid-chaperoning activities of Tat and Tat peptides made by chemical synthesis. Here we report that Tat has potent nucleic acid-chaperoning activities according to the standard DNA annealing, DNA and RNA strand exchange, RNA ribozyme cleavage and trans-splicing assays. The active Tat(44–61) peptide identified here corresponds to the smallest known sequence with DNA/RNA chaperoning properties. |
format | Text |
id | pubmed-2425468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-24254682008-06-12 The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro Kuciak, Monika Gabus, Caroline Ivanyi-Nagy, Roland Semrad, Katharina Storchak, Roman Chaloin, Olivier Muller, Sylviane Mély, Yves Darlix, Jean-Luc Nucleic Acids Res RNA The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transcriptional activator named Tat. The Tat protein is absolutely required for virus replication since it controls proviral DNA transcription to generate the full-length viral mRNA. Tat can also regulate mRNA capping and splicing and was recently found to interfere with the cellular mi- and siRNA machinery. Because of its extensive interplay with nucleic acids, and its basic and disordered nature we speculated that Tat had nucleic acid-chaperoning properties. This prompted us to examine in vitro the nucleic acid-chaperoning activities of Tat and Tat peptides made by chemical synthesis. Here we report that Tat has potent nucleic acid-chaperoning activities according to the standard DNA annealing, DNA and RNA strand exchange, RNA ribozyme cleavage and trans-splicing assays. The active Tat(44–61) peptide identified here corresponds to the smallest known sequence with DNA/RNA chaperoning properties. Oxford University Press 2008-06 2008-04-28 /pmc/articles/PMC2425468/ /pubmed/18442994 http://dx.doi.org/10.1093/nar/gkn177 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RNA Kuciak, Monika Gabus, Caroline Ivanyi-Nagy, Roland Semrad, Katharina Storchak, Roman Chaloin, Olivier Muller, Sylviane Mély, Yves Darlix, Jean-Luc The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title | The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title_full | The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title_fullStr | The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title_full_unstemmed | The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title_short | The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro |
title_sort | hiv-1 transcriptional activator tat has potent nucleic acid chaperoning activities in vitro |
topic | RNA |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2425468/ https://www.ncbi.nlm.nih.gov/pubmed/18442994 http://dx.doi.org/10.1093/nar/gkn177 |
work_keys_str_mv | AT kuciakmonika thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT gabuscaroline thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT ivanyinagyroland thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT semradkatharina thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT storchakroman thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT chaloinolivier thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT mullersylviane thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT melyyves thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT darlixjeanluc thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT kuciakmonika hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT gabuscaroline hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT ivanyinagyroland hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT semradkatharina hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT storchakroman hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT chaloinolivier hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT mullersylviane hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT melyyves hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro AT darlixjeanluc hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro |